# Serum Biomarker Levels Improvement in Poly Cystic Ovarian Syndrome: Impact of Metformin Compared to Healthy Controls

> **NCT06479434** · NA · COMPLETED · sponsor: **Aga Khan University** · enrollment: 110 (actual)

## Conditions studied

- Polycystic Ovary Syndrome
- Insulin Resistance

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT06479434
- **Lead sponsor:** Aga Khan University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-24
- **Primary completion:** 2025-05-30
- **Final completion:** 2025-10-02
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2025-10-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06479434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06479434, "Serum Biomarker Levels Improvement in Poly Cystic Ovarian Syndrome: Impact of Metformin Compared to Healthy Controls". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT06479434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*